Τόμος 15 (2001) – Τεύχος 3 – Άρθρο 4 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 15 (2001) – Issue 3 – Article 4 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Institute for Preventive Medicine, Nutrition and Cancer, Folkhälsan Research Center, and Division of Clinical Chemistry; Department of Clinical Medicine, Institute of Internal Medicine, University of Helsinki, Helsinki Finland

pharmakonpress[at]pharmakonpress[.]gr

2.    Teppo L, Pukkala E., Наkаmа M., Hakulinen A., Herva A., Saxén E.: Way of life and cancer incidence in Finland. Scand. J. Social Med. Suppl 19: 1-84 (1980)

3.    Adlercreutz H.: Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand. J. Clin. Lab. Invest. 50 (Suppl 20): 1: 3-23 (1990)

4.    Adlercreutz H.: Human health and phytoestrogens. In: Korach KS, ed. Reproductive and Developmental Toxicology. P.p. 299-371, Marcel Dekker, Inc., New York, 1998

5.    Adlercreutz H., Fotsîs T., Bannwart C., et al.: Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J. Steroid. Biochem. 25: 791-797 (1986)

6.    Adlercreutz H., Honjo H., Higashi A., et al.: Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming traditional Japanese diet. Am. J. Clin. Nutr. 54: 1093-1100 (1991)

7.    Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342: 1209-1210 (1993)

8.    Adlercreutz H.: Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect. 103 (Suppl. 7): 103-112 (1995)

9.    Mazur W.: Phytoestrogen content in foods. In: (Adlercreutz H., ed.) Phytoestrogens. P.p. 729-742, Baillière Tindall, London, 1998

10.  Mazur W., Adlercreutz H.: Overview of naturally occurring endocrine-active substances in the human diet in relation to human health. Nutrition 16: 654-658 (2000)

11.  Lock M.: Contested meanings of the menopause. Lancet 337: 1270-1272 (1991)

12.  Adlercreutz H., Hâmâlâinen E., Gorbach S., Goldin B.: Dietary phyto-oestrogens and the menopause in Japan. Lancet 339 1233(1992)

13.  Brzezinski A., Adlercreutz H., Shaoul R., Shmueli A., Reoster A., Schenker J.G.: Phytoestrogen-rich diet: A possible alternative for hormone replacement therapy. Meeting of the North American Menopause Society, Chicago, 1996

14.  Brzezinski A., Adlercreutz H., Shaoul R., et al.: Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 4: 89-94 (1997)

15.  Duncan A.M., Merz-Demlow B.E., Xu X., Phipps W.R., Kurzer M.S.: Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Third International Symposium on the role of soy in preventing and treating chronic disease 1999, Washington, October 31 to November 3

16.  Vincent A., Fitzpatrick L.A.: Soy isoflavones: Are they useful in menopause? Mayo din. Proc. 75: 1174-1184 (2000)

17.  Eden J.: Phytoestrogens and the menopause. Baillière Clin. Endocrinol. Met. 12: 581-587 (1998)

18.  Mayr U., Butsch A., Schneider S.: Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts. Toxicology 74: 35-149 (1992)

19.  Markiewicz L., Garey J., Adlercreutz H., Gurpide E.: In vitro bioassays of non-steroidal phytoestrogens. J. Steroid Biochem. Mol. Biol. 45: 399-405 (1993)

20.  Anderson J.J.B., Gamer S.C.: Phytoestrogens and bone. Baillière Clin. Endocrinol. Met. 12: 543-557 ( 1998)

21.  Alekel D.L., StGermain A., Pererson C.T., Hanson K.B., Stewart J.W., Toda T.: Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of peri-menopausal women. Am. J. Clin. Nutr. 72: 844-852 (2000)

22.  Atkinson C., Compston J.E., Robins S.P., Bingham S.A.: The effect of isoflavone phytoestrogens on bone: preliminary results from a large randomised controlled trial. Endocr. Soc. Annu. Meet. Program. (Abst.) 82: 43 (2000)

23.  Gao Y.H., Yamaguchi M.: Anabolic effect of daidzein on cortical bone in tissue culture: Comparison with genistein effect. Mol. Cell. Biochem. 194: 93-97 (1999)

24.  Pïcherit C., Coxam V., Bennetau-Pelissero C., et al.: Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J. Nutr. 130: 1675-1681 (2000)

25.  Agnusdei D., Butalino L.: Efficacy of ipriflavone in established osteoporosis and long-term safety. Calcif. Tissue Int. 61 (Suppl. 1): S23-S27 (1997)

26.  Anderson J.W., Johnstone 8.M., Cooknewell M.E.: Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333: 276-282 (1995)

27.  Merz-Demlow B.E., Duncan A.M., Wangen K.E., et al.: Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am. J. Clin. Nutr. 71: 1462-1469 (2000)

28.  Greaves K.A., Wilson M.D., Rude! L.L., Williams J.K., Wagner J.D.: Consumption of soy protein reduces cholesterol absorption compared to casein protein alone or supplemented with an isoflavone extract or conjugated equine estrogen in ovariectomized cynomolgus monkeys. J. Nutr. 130: 820-826 (2000)

29.  Howes J.B., Sullivan D., Lai N., et al.: The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post-menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152: 143-147 (2000)

30.  Anthony M.S., Clarkson T.B., Bullock. B.C., Wagner J.D.: Soy protein versus soy phytoestrogens in the prevention of diet- induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscl. Thromb. Vase. Biol. 17: 2524-2531 (1997)

31.  Anthony M.S., Clarkson T.B., .Williams J.K.: Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am. J. Clin. Nutr. 68: 1390S-1393S (1998)

32.  Squadrito F., Altavilla D., Squadrito G., et al.: Genistein supplementation and estrogen replacement therapy improve  endothelial dysfunction induced by ovariectomy in rats. Cardiovasc. Res. 45: 454-462 (2000)

33.  Simons L.A., vonKonigsmark M., Simons J., Celermajer D.S.: Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy postmenopausal women. Am, J. Cardiol. 85: 1297-1301 (2000)

34.  Tikkanen M.J., Wahala K., Ojala S., Vihma V., Adlercreutz H.: Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc. Natl. Acad. Sci. USA 95: 3106-3110 (1998)

35.  Tikkanen M.J., Adlercreutz H.: Dietary soy-derived isoflavone phytoestrogens – Could they have a role in coronary heart disease prevention? Biochem. Pharmacol. 60: 1-5 (2000)

36.  Jenkins D.J.A., Kendall C.W.C., Vidgen E., et al.: Effect of soy-based breakfast cereal on blood lipids and oxidized low- density lipoprotein. Metabolism 49: 1496-1500 (2000)

37.  Wiseman H., OReilly J.D., Adlercreutz H., et al.: Isoflavone phytoestrogens consumed in soy decrease F-2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 72: 395-400 (2000)

38.  Lissin L.W., Cooke J.P.: Phytoestrogens and cardiovascular health. J. Am. Coll. Cardiol. 35: 1403-1410 (2000)

39.  Setcheil K.D.R., Lawson A.M., Borrieilo S.P., et al.: Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet 2: 4-7 (1981)

40.  Axelson M., Sjövall J.p Gustafsson B.E., Setchell K.D.R.: Origin of lignans in mammals and identification of a precursor from plants. Nature 298: 659-660 (1982)

41.  Borrieilo S.P., Setcheil K.D.R., Axelson M., Lawson A.M.: Production and metabolism of lignans by the human faecal flora. J. Appl. Bactenol. 58: 37-43 (1985)

42.  Glitso L.V., Mazur W.M., Adlercreutz H., et al.: Intestinal metabolism of rye lignans in pigs. Br, J, Nutr. 84: 429-437 (2000)

43.  Heinonen S.p Nurmi T., Liukkonen K., et al.: In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J. Agric. Food Chem., in press (2001)

44.  Adlercreutz H., Mazur W.: Phyto-oestrogens and Western diseases. Ann. Med. 29: 95-120 (1997)

45.  Adlercreutz H., Hultén K., Mazur W., et al.: Plasma enterolactone, a biomarker of fiber intake, gut bacterial activity and breast cancer risk. International Conference on Diet and Prevention of Cancer with special emphasis on chemoprevention of cancer 1999, Tampere, Finland: Extended abstract S8., 35

46.  Kilkkinen A.p Slumpf K., Pietinen P., Valsla L.M., Tapanainen H., Adlercreutz H.: Determinants of serum enterolactone concentration. Am. J. Clin. Nutr. in press (2001)

47.  Adlercreutz H., Hockerstedt K.p Bannwarl C., et al.: Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens, and on sex hormone binding globulin (SHBG). J. Steroid. Biochem. 27: 1135-1144(1987)

48.  Adlercreutz H.p Fotsis T., Heikkinen R„ et al.: Diet and urinary excretion of lignans in female subjects. Med. Biol. 59: 259-261 (1981)

49.  Vanharanta M.p Voutilainen S.p Lakka T.A., van der Lee M., Adlercreutz H., Salonen J.T.: Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet 354: 2112- 2115 (1999)

50.  Adlercreutz H., Fotsis T,p Heikkinen R„ et al.: Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian women and in women with breast cancer. Lancet 2: 1295-1299(1982)

51.  Adlercreutz H.: Does fiber-rich food containing animal lignan precursors protect against both colon and breast cancer? An extension of the “fiber hypothesis”. Gastroenterology 86: 761- 764 (1984)

52.  Bannwart C., Fotsis T., Heikkinen R., Adlercreutz H.: Identification of the isoflavonic phytoestrogen daidzein in human urine. Clin. Chim, Acta 136: 165-172 (1984)

53.  Setcheil K.D.R., Borrieilo S.P., Hulme P.p Axelson M.: Non-steroidal estrogens of dietary origin: possible roles in hormone- dependent disease. Am. J. Clin. Nutr. 40: 569-578 (1984)

54.  Mazur W.M., Duje J.A., Wâhalâ K., Rasku S.p Adlercreutz H.: Isoflavonoids and lignans in legumes: nutritional and health aspects in humans. J. Nutr. Biochem. 9: 193-200 (1998)

55.  Kennedy A.R.: The evidence for soybean products as cancer preventive agents. J. Nutr. 125 (3 Suppl.): S733-S743 (1995)

56.  Messina M.J., Persky V., Setcheil K.D.R., Barnes S.: Soy intake and cancer risk – a review of the in vitro and in vivo data. Nutr. Cancer 21: 113-131 (1994)

57.  Hirayama T.: A large scale cohort study on cancer risk by diet – with special reference to the risk reducing effects of green-yellow vegetable consumption. In: (Hayashi Y, Nagao M, Sugimura T, et al., eds) Diet, Nutrition and Cancer. Tokyo, Utrecht: Jpn Sci. Soc. Press and VNU Sci. Press, 41-53, 1986

58.  Adlercreutz H., Hockerstedt K., Bannwart C., Hämäläinen E., Fotsis T., Bloigu S.: Association between dietary fiber, urinary excretion of lignans and isoflavonic phytoestrogens, and plasma non-protein bound sex hormones in relation to breast cancer. In: (Bresciani F., King R.J.B., Lippman M.E., Raynaud J.-P., eds) Progress in Cancer Research and Therapy, Vol. 35: Hormones and Cancer 3. New York: Raven Press, pp. 409-412, 1988

59.  Lee H.P., Gourley L., Duffy S.W., Estève J., Lee J., Day N.E.: Dietary effects on breast-cancer risk in Singapore. Lancet 337: 1197-1200(1991)

60.  Hirose K., Tajima K., Hamajima N., et al.: A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J. Cancer Res. 86: 146-54. (1995)

61.  Yuan J.M., Wang Q.S., Ross R.K., Henderson B.E., Yu M.C.: Diet and breast cancer in Shanghai and Tianjin, China. Br. J. Cancer 71: 1353-1358 (1995)

62.  Wu A.H., Ziegler R.G., Horn-Ross P.L., et al.: Tofu and risk of breast cancer in Asian-Americans. Cancer Epidem. Biomarker Prev. 5: 901-906 (1996)

63.  Greenstein J., Kushi L., Zheng W., et al.: Risk of breast cancer associated with intake of specific foods and food groups. Am. J. Epidemiol. 143 (Suppl): S36 (Abstract) (1996)

64.  Witte J.S., Ursin G., Siemiatycki J., Thompson W.D., Paganinihill A., Haile R.W.: Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Res. Treat. 42: 243-251 (1997)

65.  Ingram D., Sanders K., Kolybaba M., Lopez D.: Case-control study of phyto-oestrogens and breast cancer. Lancet 350: 990-994 (1997)

66.  Zheng W., Dai Q., Custer L.J., et al.: Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidem. Biomarker Prev. 8: 35-40 (1999)

67.  Key T.J., Sharp G.B., Appleby P.N., et al.: Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br. J. Cancerm 81: 1248-1256 (1999)

68.  Pietinen P., Stumpf K., Männistö S., Kataja V., Adlercreutz H.: Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland. Cancer Epidem. Biomarkr Prev., in press (2001)

69.  Lamartiniere C.A., Protection against breast cancer with genistein: a component of soy. Am. J. Clin. Nutr. 71: 1705S- 1707S (2000)

70.  Ziegler R.G., Hoover R.N., Pike M.C., et al.: Migration patterns and breast cancer risk in Asian-American women. J. Natl. Cancer Inst. 85: 1819-1827 (1993)

71.  Stanford J.L., Herrinton L.J., Schwartz S.M., Weiss N.S.: Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology 6: 181-183 (1995)

72.  Tominaga S., Kuroishi T.: Epidemiology of breast cancer in Japan. Cancer Lett. 90: 75-79 (1995).

73.  Adlercreutz H.: Epidemiology of phytooestrogens. In: Adlercreutz H, ed. Phytoestrogens. London: Baillière Tindall, 1998: 605-624

74.  Dalais F.S., Rice G.E., Wahfqvist ML., HsuHage B.H.H., Wattanapenpaiboon N.: Urinary excretion of isoflavonoid phytoestrogens in Chinese and Anglo-Celtic populations in Australia. Nutr. Res. 13: 1703-1709 (1998)

75.  Maskarinec G., Singh S., Meng L.X., Franke A.A.: Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidem. Biomarker. Prev. 7: 613-619 (1998)

76.  Adlercreutz H., Fotsis T., Lampe J., et al.: Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas-chromatography mass-spectrometry. Scand. J. Clin. Lab. Invest. 53 (Suppl. 215): 5-18(1993)

77.  Adlercreutz H., Honjo H., Higashi A., et al.: Urinary excretion of lignans and isofiavonoid phytoestrogens in Japanese men and women consuming traditional Japanese diet. Am. J. Clin. Nutr. 54: 1093-1100 (1991)

78.  Adlercreutz H., Mousavi Y., Höckerstedt K.: Diet and breast cancer. Acta Oncol. 31: 175-181 (1992)

79.  Rose D.P.: Dietary fiber, phytoestrogens, and breast cancer. Nutrition 8: 47-51 (1992)

80.  Rose D.P., Connolly J.M. Influence of dietary linoleic acid an experimental human breast cancer cell metastasis in athymie nude mice. Int. J. Oncol. 13: 1179-1183 (1998)

81.  Anderson J.J.B., Anthony M., Messina M., Garner S.C.: Effects of phytooestrogens on tissues. Nutr. Res. Rev. 12: 75- 116 (1999)

82.  Zaizen Y., Higuchi Y., Matsuo N., Shirabe K., Tokuda H., Takeshita M.: Antitumor effects of soybean hypocotyls and soybeans on the mammary tumor induction by N-methyl-n-nitrosourea in F344 rats. Anticancer Res. 20: 1439-44 (2000)

83.  Lamartiniere C.A., Moore J.B., Brown N.M., Thompson R., Hardin M.J., Barnes S.: Genistein suppresses mammary cancer in rats. Carcinogenesis 16: 2833-2840 (1995)

84.  Murrill W.B., Brown N.M., Zhang J.X., Manzolillo P.A., Barnes S., Lamartiniere C.A.: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17: 1451-1457 (1996)

85.  Brown N.M., Wang J., Cotroneo M.S., Zhao Y.X., Lamartiniere C.A.: Prepubertal genistein treatment modulates TGF-alpha, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol. Cell. Endocrinol. 144: 149-165 (1998)

86.  Fritz W.A., Coward L., Wang J., Lamartiniere C.A.: Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 19: 2151-2158 (1998)

87.  Ekbom A., Trichopoulos D., Adami H.O., Hsieh C.C., Lan S.J.: Evidence of prenatal influences on breast cancer risk. Lancet 340: 1015-1018 (1992)

88.  Hilakivi-Clarke L., Cho E., Onojafe I., Raygada M., Clarke R.: Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumorigenesis in female rat offspring, Oncol. Rep. 6: 1089-95 (1999)

89.  Adlercreutz H., Yamada T., Wahala K., Watanabe S.: Maternal and neonatal phytoestrogens in Japanese women during birth. Am. J. Obstet. Gynecol. 180: 737-743 (1999)

90.  Griffiths K., Adlercreutz H., Boyle P., Denis L., Nicholson R.I., Morton M.S.: Nutrition and Cancer. Oxford: ISIS Medical Media, 1996

91.  Lampe J.W., Karr S.C., Hutchins A.M., Slavin J.L.: Urinary equol excretion with a soy challenge: influence of habitual diet. Proc. Soc. Exp. Biol. Med. 217: 335-339 (1998)

92.  Rowland I.R., Wiseman H., Sanders T.A.B., Adlercreutz H., Bowey E.A.: Interindividual variation in metabolism of soy isoflavones and lignans: Influence of habitual diet on equol production by the gut microflora. Nutr. Cancer 36: 27-32 (2000)

93.  Nagata C., Kabuto M., Kurisu Y., Shimizu H.: Decreased serum estradiol concentration associated with high dietary intake of soy products in premenopausal Japanese women. Nutr. Cancer 20: 228-33 (1997)

94.  Martini M.C., Dancisak B.B., Haggans C.J., Thomas W., Slavin J.L.: Effects of soy intake on sex hormone metabolism in premenopausal women. Nutr. Cancer 34: 133-139 (1999)

95.  Lu L.J.W, Cree M., Josyula S., Nagamanî M., Grady J.J., Anderson K.E.: Increased urinary excretion of 2-hydroxyestrone but not 16 alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. Cancer Res. 60: 1299-1305 (2000)

96.  Duncan A.M., Merz-Demlow B.E., Xu X., Phipps W.R., Kurzer M.S.: Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidem. Biomarker Prev. 9: 581-586 (2000)

97.  Xu X., Duncan A.M., Wangen K.E., Kurzer M.S.: Soy consumption alters endogenous estrogen metabolism in post-menopausal women. Cancer Epidem. Biomarker Prev. 9: 781- 786 (2000)

98.  Wu A.H., Stanczyk F.Z., Hendrich S., et al.: Effects of soy foods on ovarian function in premenopausal women, Br. J. Cancer 82: 1879-1886 (2000)

99.  Hirose M., Yamaguchi T., Lin C., et al.: Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MelQx-induced hepatocarcinogenesis in male F344 rats. Cancer Lett. 155: 79-88 (2000)

100. Serraino M., Thompson L.U.: The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr. Cancer 17: 153-159 (1992)

101. Thompson L.U., Rickard S.E., Orcheson L.J., Seidl M.M.: Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 17: 1373-1376(1996)

102. Thompson L.U., Seidl M.M., Rickard S.E., Orcheson L.J., Fong H.H.S.: Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 26: 159-165 (1996)

103. Rickard S.E., Yuan Y.V., Chen J.M., Thompson L.U.: Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea- induced mammary tumorigenesis in rats. Nutr. Cancer 35: 50- 57(1999)

104. Pietinen P., Lusa K., Kilkkinen A., et at.: Determinants of plasma enterolactone and its associations with the risk of prostate and breast cancer. International Conference on Diet and Prevention of Cancer, with special emphasis on chemoprevention of cancer 1999, Tampere, Finland: S8.36

105. Hultén K., Winkvist A., Leaner P., Johansson R., Adlercreutz H., Hallmans G.: An incident case-referent study on the lignan enterolactone and breast cancer. Am. J. Epidemoil. submitted (2001)

106. Yatani R., Chigusa L, Akazaki K., Stemmerman G.N., Welsh R.A., Correa P.: Geographic pathology of latent prostatic cancer. Int. J. Cancer 29: 611-616 (1982)

107. Severson R.K., Nomura A.M.Y., Grove J.S., Stemmerman G.N.: A prospective study of demographics and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 49: 1857-1860 (1989)

108. Le Marchand L., Kolonel L.N., Wilkens L.R., Myers B.C., Hirohata T.: Animal fat consumption and prostate cancer – a prospective study in Hawaii. Epidemiology 5: 276-282 (1994)

109. Hirayama T. Epidemiology of prostate cancer with special reference to the role of diet. Natl. Inst. Monogr. 53: 149-155 (1979)

110. Strom S.S., Yamamura Y., Duphorne C.M., et al.: Phytoestrogen intake and prostate cancer: A case-control study using a new database. Nutr. Cancer 33: 20-25 (1999)

111. Kolonel L.N., Hankin J.H., Whittemore A.S., et al.: Vegetables, fruits, legumes and prostate cancer: A multiethnic case- control study. Cancer Epidem. Biomarker Prev. 9: 795-804 (2000)

112. Kuiper G.G.J.M., Enmark E., Petto-Hukko M., Nilsson S., Gustafsson J.-Â.: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93: 5925-5930 (1996)

113. Kuiper G.G.J.M., Lemmen J.G., Carlsson B., et al.: interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139: 4252-4263 (1993)

114. Ogawa S., Inoue S., Watanabe T., et at.: Molecular cloning and characterization of human estrogen receptor beta cx: a potential inhibitor of estrogen action in human. Nucleic Acids Res. 26: 3505-3512(1998)

115. Adlercreutz C.H.T., Goldin B.R., Gorbach S.L., et al.: Soy-bean phytoestrogen intake and cancer risk. J. Nutr. 125 (3Suppl.): S757-S770 (1995)

116. Morton M.S., Chan P.S.F., Cheng C., et al.: Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kinqdom. Prostate 32: 122-128(1997)

117. Sharma O.P., Adlercreutz H., Strandberg J.D., Zirkin B.R., Coffey D.S., Ewing L.L.: Soy of dietary source plays a preventive role against pathogenesis of prostatitis in rats. J. Steroid Biochem. Mol. Biol. 43: 557-564 (1992)

118. Peterson G., Barnes S.: Genistein and Biochanin-A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22: 335-345 (1993)

119. Naik H.R., Lehr J.E., Pienta K.J.: An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Anticancer Res. 14: 2617-2619 (1994)

120. Adlercreutz H., Makela S., Pylkkânen L., et al.: Dietary phytoestrogens and prostate cancer. 86th Annual Meeting of the American Association for Cancer Research, Toronto, Ontario, Canada, 687, 1995

121. Rokhiin O.W., Cohen M.B.: Differential sensitivity of human prostatic cancer cell lines to the effects of protein kinase and phosphatase inhibitors. Cancer Lett. 93: 103-110 (1995)

122. Adlercreutz H., Bartels P., Elomaa V.-V., Kang C.: Phytoestrogens and prostate cancer. Soy & Health 2000. Clinical evidence – Dietetic applications 2000, Oct 13-14; Brussels, Belgium, in press.

123. Makela S.I., Pylkkânen L.H., Santti R.S., Adlercreutz H.: Dietary soybean may be antiestrogenic in male mice. J. Nutr. 125: 437-445(1995)

124. Pollard M., Luckert P.H.: Influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutr. Cancer 28: 41-45 (1997)

125. Onozawa M., Kawamori T., Baba M., et al.: Effects of a soybean isoflavone mixture on carcinogenesis in prostate and seminal vesicles of F344 rats. Jpn J. Cancer Res. 90: 393-398 (1999)

126. Aronson W.J., Tymchuk C.N., Elashoff R.M., et al.: De-creased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. Nutr. Cancer 35: 130-6 (1999)

127. Zhou J.R., Gugger E.T., Tanaka T., Guo Y.P., Blackburn G.L., Clinton S.K.: Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J. Nutr. 129: 1628-1635 (1999)

128. Fotsis T., Pepper M., Adlercreutz H., et al.: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA 90: 2690-2694 (1993)

129. Schleicher R.L., Lamartiniere C.A., Zheng M., Zhang M.: The inhibitory effect of genistein on the growth and metastasis of a transplantable rat accessory sex gland carcinoma. Cancer Lett. 136: 195-201 (1999)

130. Landström M., Zhang J.X., Hallmans G., et al.: Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 36: 151-161 (1998)

131. Bylund A., Zhang J.-.X, Bergh A., et al.: Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate 42: 304-314 (1998)

132. Oesterlîng J.E., Kumamoto Y., Tsukamoto T., et al.: Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white man. Br. J. Urol. 75: 347-353 (1995)

133. Adlercreutz H., Bannwart C., Wähälä K., et al.: Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J. Steroid Biochem. Mol. Biol. 44: 147-153 (1993)

134. Wang C.F., Makela T., Hase T., Adlercreutz H., Kurzer M.S.: Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J. Steroid Biochem. Mol. Biol. 50: 205- 212 (1994)

135. Evans B.A.J., Griffiths K., Morton M.S.: Inhibition of 5a-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J. Endocrinol. 147: 295-302 (1995)

136. Messina M., Bennink M.: Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data. Baillière Clin. Endocrinol. Met. 12: 707-728 (1998)

137. Thiagarajan D.G., Bennink M.R., Bourquin L.D., Kavas F.A.: Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. Am. J. Clin. Nutr. 68: 1394S-1399S (1998)

138. Sorensen I.K., Kristiansen E.A.,M., et al.: The effect of soy isoflavones on the development of intestinal neoplasia in ApcMin mouse. Cancer Lett. 130: 217-225 (1998)

139. Davies M.J., Bowey E.A., Adlercreutz H., Rowland I.R., Rumsby P.C.: Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats. Carcinogenesis 20 927-931 (1999)

140. Rao C.V., Wang C.X., Simi B., et al.: Enhancement of experimental colon cancer by genistein. Cancer Res. 57: 3717- 3722 (1997)

141. Serraino M., Thompson L.U.: Flaxseed supplementation and early markers of colon carcinogenesis. Cancer Lett. 63: 159-165 (1992}

142. Thompson L.U.: Experimental studies on lignans and cancer. Baillière Clin. Endocrinol. Met. 12: 691-705 (1998)

143. Mutanen M., Pajari A.-M., Oikarinen S.I.: Beef induces and rye bran prevents the formation of intestinal polyps in ApcMin mice: relation to β-catenin and PKC isozymes. Carcinogenesis 21: 1167-1173 (2000)

144. Saarinen N.M., Wärri A., Mäkelä S.I., et al.: Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr. Cancer 36: 207- 16(2000)

145. Oikarinen S.I., Pajari A.-M., Mutanen M.: Chemopreventive activity of crude hydroxymatairesinol (HMR) extract in ApcMin mice. Cancer Lett. 161: 253.258 (2000)

146. Liukkonen K,, Heinonen S., Nurmi T., Mazur W., Poutanen K., Adlercreutz H.: Formation of enterolactone during in vitro fermentation of rye (poster). 2000 AACC Annual Meeting. 2000 Nov 5-9: 2000, Kansas City, Missouri

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr